2nyr: Difference between revisions

New page: left|200px<br /> <applet load="2nyr" size="450" color="white" frame="true" align="right" spinBox="true" caption="2nyr, resolution 2.06Å" /> '''Crystal Structure o...
 
No edit summary
 
(17 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:2nyr.gif|left|200px]]<br />
<applet load="2nyr" size="450" color="white" frame="true" align="right" spinBox="true"
caption="2nyr, resolution 2.06&Aring;" />
'''Crystal Structure of Human Sirtuin Homolog 5 in Complex with Suramin'''<br />


==Overview==
==Crystal Structure of Human Sirtuin Homolog 5 in Complex with Suramin==
Sirtuins are NAD(+)-dependent protein deacetylases and are emerging as, molecular targets for the development of pharmaceuticals to treat human, metabolic and neurological diseases and cancer. To date, several sirtuin, inhibitors and activators have been identified, but the structural, mechanisms of how these compounds modulate sirtuin activity have not yet, been determined. We identified suramin as a compound that binds to human, SIRT5 and showed that it inhibits SIRT5 NAD(+)-dependent deacetylase, activity with an IC(50) value of 22 microM. To provide insights into how, sirtuin function is altered by inhibitors, we determined two crystal, structures of SIRT5, one in complex with ADP-ribose, the other bound to, suramin. Our structural studies provide a view of a synthetic inhibitory, compound in a sirtuin active site revealing that suramin binds into the, NAD(+), the product, and the substrate-binding site. Finally, our, structures may enable the rational design of more potent inhibitors.
<StructureSection load='2nyr' size='340' side='right'caption='[[2nyr]], [[Resolution|resolution]] 2.06&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[2nyr]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=2fzq 2fzq]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2NYR OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2NYR FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.06&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SVR:8,8-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC+ACID'>SVR</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2nyr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2nyr OCA], [https://pdbe.org/2nyr PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2nyr RCSB], [https://www.ebi.ac.uk/pdbsum/2nyr PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2nyr ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/SIR5_HUMAN SIR5_HUMAN] NAD-dependent lysine demalonylase and desuccinylase that specifically removes malonyl and succinyl groups on target proteins. Activates CPS1 and contributes to the regulation of blood ammonia levels during prolonged fasting: acts by mediating desuccinylation of CPS1, thereby increasing CPS1 activity in response to elevated NAD levels during fasting. Activates SOD1 by mediating its desuccinylation, leading to reduced reactive oxygen species. Has weak NAD-dependent protein deacetylase activity; however this activity may not be physiologically relevant in vivo. Can deacetylate cytochrome c (CYCS) and a number of other proteins in vitro.<ref>PMID:18680753</ref> <ref>PMID:21908771</ref> <ref>PMID:24140062</ref> <ref>PMID:22076378</ref>
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
Check<jmol>
  <jmolCheckbox>
    <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/ny/2nyr_consurf.spt"</scriptWhenChecked>
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
    <text>to colour the structure by Evolutionary Conservation</text>
  </jmolCheckbox>
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2nyr ConSurf].
<div style="clear:both"></div>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Sirtuins are NAD(+)-dependent protein deacetylases and are emerging as molecular targets for the development of pharmaceuticals to treat human metabolic and neurological diseases and cancer. To date, several sirtuin inhibitors and activators have been identified, but the structural mechanisms of how these compounds modulate sirtuin activity have not yet been determined. We identified suramin as a compound that binds to human SIRT5 and showed that it inhibits SIRT5 NAD(+)-dependent deacetylase activity with an IC(50) value of 22 microM. To provide insights into how sirtuin function is altered by inhibitors, we determined two crystal structures of SIRT5, one in complex with ADP-ribose, the other bound to suramin. Our structural studies provide a view of a synthetic inhibitory compound in a sirtuin active site revealing that suramin binds into the NAD(+), the product, and the substrate-binding site. Finally, our structures may enable the rational design of more potent inhibitors.


==About this Structure==
Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin.,Schuetz A, Min J, Antoshenko T, Wang CL, Allali-Hassani A, Dong A, Loppnau P, Vedadi M, Bochkarev A, Sternglanz R, Plotnikov AN Structure. 2007 Mar;15(3):377-89. PMID:17355872<ref>PMID:17355872</ref>
2NYR is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with SVR and ZN as [http://en.wikipedia.org/wiki/ligands ligands]. This structure superseeds the now removed PDB entry 2FZQ. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2NYR OCA].


==Reference==
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin., Schuetz A, Min J, Antoshenko T, Wang CL, Allali-Hassani A, Dong A, Loppnau P, Vedadi M, Bochkarev A, Sternglanz R, Plotnikov AN, Structure. 2007 Mar;15(3):377-89. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17355872 17355872]
</div>
<div class="pdbe-citations 2nyr" style="background-color:#fffaf0;"></div>
 
==See Also==
*[[Histone deacetylase 3D structures|Histone deacetylase 3D structures]]
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Large Structures]]
[[Category: Allali-Hassani, A.]]
[[Category: Allali-Hassani A]]
[[Category: Antoshenko, T.]]
[[Category: Antoshenko T]]
[[Category: Arrowsmith, C.H.]]
[[Category: Arrowsmith CH]]
[[Category: Bochkarev, A.]]
[[Category: Bochkarev A]]
[[Category: Dong, A.]]
[[Category: Dong A]]
[[Category: Edwards, A.M.]]
[[Category: Edwards AM]]
[[Category: Min, J.R.]]
[[Category: Min JR]]
[[Category: Plotnikov, A.N.]]
[[Category: Plotnikov AN]]
[[Category: SGC, Structural.Genomics.Consortium.]]
[[Category: Sundstrom M]]
[[Category: Sundstrom, M.]]
[[Category: Weigelt J]]
[[Category: Weigelt, J.]]
[[Category: SVR]]
[[Category: ZN]]
[[Category: histone deacetylase]]
[[Category: hydrolase]]
[[Category: sgc]]
[[Category: structural genomics]]
[[Category: structural genomics consortium]]
 
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 23:04:18 2007''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA